Related to CDI, Coriell Win $26M Toward iPSC Lines, Biorepository

• New Life for Embryonic Stem Cells
  Positive results from new studies show that ESCs still hold much potential for regenerative medicine.
  
• Top 10 VC & Biopharma Equity Deals of 2012
  Which companies raised the most funds last year?
  
• Bioprinting in 3D
  Scientists are working on extending the principles of 3D printing to constructing organs and tissues using bioprinters.
  
• Top 20 Best-Selling Drugs of 2012
  Which drugs were the biggest hits last year?
  
• Top 20 Biopharma R&D Spenders
  Which companies have the deepest pockets for research and development?
  
• Is Brain Mapping Ready for Big Science?
  The BAM project will be an expensive undertaking. Will it be worth the cost?
  
• Top 22 R&D Spenders among Tool and Technologies Companies
  Find out how much money goes into developing the instruments you use for research.
  
• Top 20 Best-Selling Drugs Approved and Launched During 2012
  What new medicines are shaking things up?
  
• CEO Perks
  These 18 top dogs have got it good.
  
• Two Roads to Wowing the Crowd
  Poliwogg eyes biopharma startups seeking millions; Microryza connects donors to researchers needing thousands.
  
• GEN Congressional Hall of Fame
  Biomedical research has friends in high places. Meet them.
  
• Literature Review: A Step Closer to Personalized Medicine
  Researchers use patient-specific cell lines derived in mice to personalize chemotherapy.
  
• Reporting from J.P. Morgan Healthcare Conference
  Drug companies developing companion diagnostics is just one of the trends highlighted at the meeting.
  
• Advancing Stem Cell Therapies for Multiple Sclerosis
  UKSCF partners with MS Society to financially support clinical development.
  
• NIH Taps 25 Schools to Receive Top Dollars
  Did your alma mater make the list?
  
• Prizes and Quackery Dominate iPS Cell News
  Through ups and downs, the question remains: Do induced pluripotent stem cells have near-term clinical potential?
  
• In Vitro Clinical Trials: Not that Far-Fetched
  Scientists foresee a time when induced pluripotent stem cells could be used to predict patients’ response to a drug.
  
• SBIR Thinks Smaller
  New rules taking effect on January 28 aim to draw investor-owned smaller biopharmas to the federal grant program and STTR, its companion.
  
• Funding Squeeze Traps Young Researchers
  Postdocs look beyond NIH funding as, despite policy changes, the percentage and age of first-time grant winners stay steady.
  
• 20 Grants for Young Researchers
  Looking for funding? Here are some places to start.